{"entity":{"type":"insider","cik":"0001824542","url":"/insider/0001824542","json_url":"/insider/0001824542.json","name":"Beskrovnaya Oxana","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":22,"first":"2021-09-22","last":"2025-03-13","span_basis":"filed_date"},"name_variants":[{"name":"Beskrovnaya Oxana","source":"filing","n_filings":22,"first_seen":"2021-09-22","last_seen":"2025-03-13"}],"transactions":[{"id":5074133,"accession":"0000950170-25-038726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-038726","line_url":"/filing/0000950170-25-038726#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2153.0,"shares_display":"2,153","price_per_share":11.38,"price_display":"11.38","price_state":"stated","total_value":24501.14,"total_display":"24,501.14","total_whole":"24,501","shares_owned_after":195840.0,"shares_owned_after_display":"195,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-13","scope":"insider"},{"id":5117183,"accession":"0000950170-25-035472","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-035472","line_url":"/filing/0000950170-25-035472#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1094.0,"shares_display":"1,094","price_per_share":11.83,"price_display":"11.83","price_state":"stated","total_value":12942.02,"total_display":"12,942.02","total_whole":"12,942","shares_owned_after":197993.0,"shares_owned_after_display":"197,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":4416402,"accession":"0000950170-25-026837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-026837","line_url":"/filing/0000950170-25-026837#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2598.0,"shares_display":"2,598","price_per_share":13.95,"price_display":"13.95","price_state":"stated","total_value":36242.1,"total_display":"36,242.10","total_whole":"36,242","shares_owned_after":199087.0,"shares_owned_after_display":"199,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-25","scope":"insider"},{"id":3153029,"accession":"0000950170-24-135571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-135571","line_url":"/filing/0000950170-24-135571#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2334.0,"shares_display":"2,334","price_per_share":28.12,"price_display":"28.12","price_state":"stated","total_value":65632.08,"total_display":"65,632.08","total_whole":"65,632","shares_owned_after":201685.0,"shares_owned_after_display":"201,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-11","scope":"insider"},{"id":2143357,"accession":"0000950170-24-127989","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-127989","line_url":"/filing/0000950170-24-127989#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2856.0,"shares_display":"2,856","price_per_share":28.2,"price_display":"28.20","price_state":"stated","total_value":80539.2,"total_display":"80,539.20","total_whole":"80,539","shares_owned_after":137519.0,"shares_owned_after_display":"137,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-18","filed_date":"2024-11-18","scope":"insider"},{"id":2206370,"accession":"0000950170-24-108151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-108151","line_url":"/filing/0000950170-24-108151#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2339.0,"shares_display":"2,339","price_per_share":34.55,"price_display":"34.55","price_state":"stated","total_value":80812.45,"total_display":"80,812.45","total_whole":"80,812","shares_owned_after":140375.0,"shares_owned_after_display":"140,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-19","scope":"insider"},{"id":2177807,"accession":"0000950170-24-105517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-105517","line_url":"/filing/0000950170-24-105517#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2161.0,"shares_display":"2,161","price_per_share":31.89,"price_display":"31.89","price_state":"stated","total_value":68914.29,"total_display":"68,914.29","total_whole":"68,914","shares_owned_after":142714.0,"shares_owned_after_display":"142,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-11","scope":"insider"},{"id":2461608,"accession":"0000950170-24-099122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-099122","line_url":"/filing/0000950170-24-099122","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2636.0,"shares_display":"2,636","price_per_share":45.121168437025794,"price_display":"45.12","price_state":"stated","total_value":118939.4,"total_display":"118,939.40","total_whole":"118,939","shares_owned_after":145171.0,"shares_owned_after_display":"145,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":3152367,"accession":"0000950170-24-072170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-072170","line_url":"/filing/0000950170-24-072170#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2136.0,"shares_display":"2,136","price_per_share":31.34,"price_display":"31.34","price_state":"stated","total_value":66942.24,"total_display":"66,942.24","total_whole":"66,942","shares_owned_after":147511.0,"shares_owned_after_display":"147,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-11","scope":"insider"},{"id":2417080,"accession":"0000950170-24-063737","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-063737","line_url":"/filing/0000950170-24-063737","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30426.0,"shares_display":"30,426","price_per_share":32.95705087753895,"price_display":"32.96","price_state":"stated","total_value":1002751.23,"total_display":"1,002,751.23","total_whole":"1,002,751","shares_owned_after":162939.0,"shares_owned_after_display":"162,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider","n_lines":3},{"id":2736184,"accession":"0000950170-24-062080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-062080","line_url":"/filing/0000950170-24-062080","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2705.0,"shares_display":"2,705","price_per_share":28.269637707948245,"price_display":"28.27","price_state":"stated","total_value":76469.37,"total_display":"76,469.37","total_whole":"76,469","shares_owned_after":150130.0,"shares_owned_after_display":"150,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2415777,"accession":"0000950170-24-030443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-030443","line_url":"/filing/0000950170-24-030443#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2081.0,"shares_display":"2,081","price_per_share":25.7,"price_display":"25.70","price_state":"stated","total_value":53481.7,"total_display":"53,481.70","total_whole":"53,482","shares_owned_after":152352.0,"shares_owned_after_display":"152,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":2983425,"accession":"0000950170-24-029615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-029615","line_url":"/filing/0000950170-24-029615#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2373.0,"shares_display":"2,373","price_per_share":25.85,"price_display":"25.85","price_state":"stated","total_value":61342.05,"total_display":"61,342.05","total_whole":"61,342","shares_owned_after":154433.0,"shares_owned_after_display":"154,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":2823915,"accession":"0000950170-24-002279","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-002279","line_url":"/filing/0000950170-24-002279#line-6","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42453.0,"shares_display":"42,453","price_per_share":18.13,"price_display":"18.13","price_state":"stated","total_value":769672.89,"total_display":"769,672.89","total_whole":"769,673","shares_owned_after":156806.0,"shares_owned_after_display":"156,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-04","scope":"insider"},{"id":2823906,"accession":"0000950170-24-002279","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-002279","line_url":"/filing/0000950170-24-002279","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45326.0,"shares_display":"45,326","price_per_share":18.98055266293077,"price_display":"18.98","price_state":"stated","total_value":860312.53,"total_display":"860,312.53","total_whole":"860,313","shares_owned_after":181946.0,"shares_owned_after_display":"181,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider","n_lines":3},{"id":8471461,"accession":"0001209191-23-058326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058326","line_url":"/filing/0001209191-23-058326#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1467.0,"shares_display":"1,467","price_per_share":10.72,"price_display":"10.72","price_state":"stated","total_value":15726.24,"total_display":"15,726.24","total_whole":"15,726","shares_owned_after":176585.0,"shares_owned_after_display":"176,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":8440879,"accession":"0001209191-23-050168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050168","line_url":"/filing/0001209191-23-050168#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1436.0,"shares_display":"1,436","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":13512.76,"total_display":"13,512.76","total_whole":"13,513","shares_owned_after":84334.0,"shares_owned_after_display":"84,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":8726827,"accession":"0001209191-23-049356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049356","line_url":"/filing/0001209191-23-049356#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1484.0,"shares_display":"1,484","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":15448.44,"total_display":"15,448.44","total_whole":"15,448","shares_owned_after":85770.0,"shares_owned_after_display":"85,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":8404086,"accession":"0001209191-23-037163","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037163","line_url":"/filing/0001209191-23-037163#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1475.0,"shares_display":"1,475","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":18334.25,"total_display":"18,334.25","total_whole":"18,334","shares_owned_after":87254.0,"shares_owned_after_display":"87,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":7897155,"accession":"0001209191-23-018977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018977","line_url":"/filing/0001209191-23-018977#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1416.0,"shares_display":"1,416","price_per_share":13.33,"price_display":"13.33","price_state":"stated","total_value":18875.28,"total_display":"18,875.28","total_whole":"18,875","shares_owned_after":88729.0,"shares_owned_after_display":"88,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"},{"id":6658910,"accession":"0001209191-22-060964","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060964","line_url":"/filing/0001209191-22-060964#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":680.0,"shares_display":"680","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":7391.6,"total_display":"7,391.60","total_whole":"7,392","shares_owned_after":90145.0,"shares_owned_after_display":"90,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider"},{"id":6607655,"accession":"0001209191-22-018530","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018530","line_url":"/filing/0001209191-22-018530#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":693.0,"shares_display":"693","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":6049.89,"total_display":"6,049.89","total_whole":"6,050","shares_owned_after":53676.0,"shares_owned_after_display":"53,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":4540073,"accession":"0001209191-21-057323","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057323","line_url":"/filing/0001209191-21-057323#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":827.0,"shares_display":"827","price_per_share":16.11,"price_display":"16.11","price_state":"stated","total_value":13322.97,"total_display":"13,322.97","total_whole":"13,323","shares_owned_after":17845.0,"shares_owned_after_display":"17,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider"},{"id":4540071,"accession":"0001209191-21-057323","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057323","line_url":"/filing/0001209191-21-057323#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824542","owner_name":"Beskrovnaya Oxana","owner_display_name":"Beskrovnaya Oxana","owner_url":"/insider/0001824542","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":617.0,"shares_display":"617","price_per_share":15.61,"price_display":"15.61","price_state":"stated","total_value":9631.37,"total_display":"9,631.37","total_whole":"9,631","shares_owned_after":18672.0,"shares_owned_after_display":"18,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Officer (Chief Scientific Officer)","n_filings":22,"first_seen":"2021-09-22","last_seen":"2025-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001824542","retrieved_at":"2026-08-25T15:34:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}